Navigation Links
Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
Date:5/11/2012

NANJING, China, May 11, 2012 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group (NYSE: SCR) ("Simcere" or the "Company"), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced that the annual general meeting of shareholders (the "Meeting") will be held on Friday, May 25, 2012 at 10 a.m. Beijing time. The meeting will be held at No.699-18, Xuanwu Avenue, Xuanwu District, Nanjing, the People's Republic of China.

The meeting's main purposes are:

  1. To receive a report on the Company's operations.
  2. To transact any other business properly brought before the Meeting.

All shareholders of record at the close of business on May 11, 2012 will be entitled to attend and vote at the Meeting, and at any adjournment or postponement thereof, or to appoint a proxy to attend and vote in his/her place. The proxy need not be a shareholder of the Company.

This notice and other information with regards to the Meeting are available on the investor relations section of the Company's website: www.simcere.com.

About Simcere Pharmaceutical GroupSimcere Pharmaceutical Group ("Simcere") (NYSE: SCR) is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China. Simcere concentrates its research and development efforts on the treatment of diseases with high incidence and/or mortality rates and for which there is a clear demand for more effective pharmacotherapy such as cancer, strokes, cardiovascular disease, infectious diseases and pain. For more information about Simcere Pharmaceutical Group, please visit www.simcere.com. Investor and Media Contacts:  Email: ir@simcere.com

 In Nanjing:In the United States:Yehong Zhang

Cindy ZhengPresident

Brunswick Group LLCSimcere Pharmaceutical GroupTel: 1-212-333-3810Tel: 86-25-8556-6666 ext 8811In Beijing:In Hong Kong:Yue Yu

Joseph Lo Chi-LunBrunswick Group

Brunswick GroupTel: 86-10-5960-8600

Tel: 852-3512-5000 


'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study
2. Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals
3. Simcere Pharmaceutical Group to Acquire Additional Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd.
4. Simcere Pharmaceutical Group Announces Jiangsu Yanshens Voluntary Suspension of Production
5. Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen
6. Simcere Receives SFDA Approval to Manufacture and Sell Zanamivir in China
7. Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2009 Unaudited Financial Results on Tuesday, March 16, 2010
8. Simcere Pharmaceutical Group Successfully Completes Endostar Phase IV Clinical Study
9. Simceres Diosmectite API Passes EU-GMP Inspection
10. Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2010 Results
11. Simcere Pharmaceutical Group Files Annual Report on Form 20-F
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2019)... ... November 06, 2019 , ... ... today unveiled new research exploring mobile behaviors that are associated with higher weight ... Presented at ObesityWeek 2019, the new study, “Mobile Engagement Behaviors Associated With Sustained ...
(Date:11/5/2019)... ... 2019 , ... Modern Living Living with kathy ireland® is pleased ... Heidi Reaganass and Head of Channel Partnerships and Media Relations Monty Bernardi to discuss ... Goli Nutrition is a nutrition company. Their goal is to help people reach their ...
(Date:11/5/2019)... ... November 05, 2019 , ... ... How to Build a Sponsor Risk Management Program, Friday, Nov. 15: Supplier/Vendor/Contractor ... 13-15, 2019 • Philadelphia, PA , https://www.fdanews.com/cwiche6gcp , ICH E6 ...
Breaking Medicine Technology:
(Date:11/11/2019)... ... November 11, 2019 , ... American Family ... occupational medicine, is expanding its long-term partnership with 919 Marketing , a ... With more than 200 locations across the country, American Family Care (AFC) is ...
(Date:11/9/2019)... ... November 08, 2019 , ... Pennsylvania College ... pleased to announce that after the fourth quarter of the 2018-2019 academic year, ... 94.73% average pass rate. The College’s annual pass rate for the 2018-2019 academic ...
(Date:11/7/2019)... ... 07, 2019 , ... ALZYN, LLC today announced that The Silicon Review Magazine ... , “The Silicon Review 50 Best Companies to Watch 2019 program identifies companies which ... and winning a spot on this list indicates the company has distinguished itself from ...
(Date:11/6/2019)... ... November 06, 2019 , ... Nellson, ... bar and functional powder solutions, recently achieved FSSC 22000 Certification of GFSA standard ... pleased to share the news that we have achieved FSSC 22000 compliance at ...
(Date:11/6/2019)... ... November 06, 2019 , ... Conducting Advanced ... to Improve Inspections, An FDAnews Workshop, Nov. 13-14, 2019 • Philadelphia, PA, ... one week. , Dear FDA-Regulated Executive, , CAPA failures show up in about ...
Breaking Medicine News(10 mins):